Aviva stock gains as RBC reiterates outperform rating and 780p target

Published on 09/07/2026 at 21:15 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Aviva stock is edging higher after Royal Bank of Canada reiterated its outperform rating and 780p price target, underscoring a moderate buy consensus and highlighting the insurer’s valuation discount to UK peers.

Schwarzweißfoto von Berufspendlern in Londons Finanzviertel mit Wolkenkratzern — Aviva plc (ISIN GB0002162385) dokumentiert eine Schwarzweiß-Straßenszene im Finanzdistrikt Londons mit vielen Berufspendlern, Illustration mit AI erstellt.

Aviva plc (ISIN GB0002162385) stock was trading at about 729.80 pence on the London Stock Exchange as of September 7, 2026, supported by a reiterated outperform rating and a 780p price target from Royal Bank of Canada that points to roughly 6.9 percent upside from the prior close.

RBC reiterates view and highlights upside

According to MarketBeat data reflecting Royal Bank of Canada’s latest research note on September 7, 2026, the broker maintained its outperform rating on Aviva and kept a price objective of 780p per share, indicating potential upside of 6.88 percent from the previous closing level around 729.80p.

A separate summary of analyst views shows Aviva holding a consensus rating of moderate buy with an average price target near 739.75p, suggesting the RBC target remains at the upper end of expectations while still broadly aligned with the market’s constructive stance on the stock.

Analyst consensus and valuation context

In addition to the RBC call, analyst coverage compiled by TipRanks indicates that Aviva has a moderate buy consensus with a price target consensus of roughly 752.00p, slightly above the current share price of 729.80p as of the latest close, which implies mid-single-digit percentage upside if the consensus is achieved.

RBC Capital Markets noted after hosting Aviva’s chief financial officer Charlotte Jones on its “Back-to-School” investor call series that the group’s diversified earnings mix has not fully translated into valuation, with Aviva continuing to trade at about a 16 percent discount to UK peers on forward earnings, a gap that is central to the upside case highlighted in the 780p target.

Business mix and earnings drivers

While the latest broker commentary focuses on valuation and capital management, it also implicitly underscores Aviva’s multi-line business profile, spanning life insurance, general insurance and asset management activities in the UK and selected international markets, which together drive the earnings streams that analysts expect to support the medium-term growth implied by current price targets.

The RBC analysis, as summarized in recent coverage, points out that this diversified earnings base could justify a smaller discount to peers over time if Aviva can continue to deliver steady operating profit growth and maintain disciplined capital returns, particularly dividends and potential buybacks, although the precise recent profit figures lie outside the very latest week-filtered sources and therefore serve as historical context rather than current core metrics.

Key product: Aviva life and retirement offerings

For many retail and institutional customers, Aviva’s core franchise centers on its branded life insurance and retirement products in the UK, which package long-term savings, protection and income solutions and represent a significant contributor to the group’s earnings mix referenced by analysts when assessing both the 780p RBC target and the broader 752.00p consensus.

Stock price and market metrics

Market data summarized by MarketBeat and other analyst aggregators show Aviva shares opened around 729.80p on the latest London session, up approximately 0.7 percent compared with the prior close, with a 12-month low reported at 390.70p and a 12-month high at 510.20p as of the same data snapshot, indicating that the current level sits significantly above the low yet well above the historical high range used in earlier periods within the source snippet.

Based on recent market snapshots for LSE-listed insurers, Aviva’s market capitalization at a share price near 729.80p is in the multi-billion pound range as of early September 2026, underscoring the stock’s relevance for investors tracking UK financials, even though the precise market cap figure is not explicitly stated in the latest week-filtered sources and therefore remains a contextual indication rather than a quoted core metric.